FIRM FIXED PRICENO SET ASIDE USED.
XLCARE PHARMACEUTICALS INC - 2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS.
PIID: 36E79721D0051Solicitation ID: 36E79721R0039
Signed Date: Oct 9, 2025Effective Date: Dec 23, 2021
Key Details
Description
2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.